Based in central London William Harvey Research Ltd provides preclinical contract research for the Biotech and Pharmaceutical industry, with the aim of offering the most professional service to our customers in bespoke study design and advice, alongside high quality academic input.
Our History
Named after the English physician who made seminal contributions to anatomy and physiology, William Harvey Research Limited (WHRL) was established in 1990 by the Nobel Laureate Sir John Vane, FRS, to facilitate interaction between academia and the pharmaceutical industry.
Since then we have worked with over 100 biotech and pharmaceutical companies and continue to lead the way as a Preclinical Contract Research Organisation.
Our Work
A primary aim of WHRL is to co-ordinate contract research as an Efficacy, Verification and Interpretation Service (EVIS). Scientific personnel of the William Harvey Research Institute provide the foundation of experience and expertise to complement drug development for biotech and pharmaceutical companies.
Our Vision
From preclinical contract research and bespoke study design to long-term collaboration with strategic partners, WHRL provides a high-quality contract research service to global biotechnology and pharmaceutical companies.
Our experienced scientists offer:
Excellent standards of research
Bespoke study design
Broad range of models and therapeutic areas
Advice from world-leading academic experts
Detailed and professional final reports
For over 20 years we have been leading the way as a contract research organisation for the Biotech and Pharmaceutical sectors. We offer a preclinical drug evaluation service specialising in models of cardiovascular and inflammatory diseases.
© 2024 coursetakers.com All Rights Reserved. Terms and Conditions of use | Privacy Policy